Comparison of Two Type of Laryngeal Mask : I-Gel & LMA ProSeal (I-Gel)

May 27, 2026 updated by: University Hospital, Bordeaux

LMA ProSeal & I-Gel : a Prospective Controlled Trial

The i-gel is a new supra glottic airway device with a non inflatable cuff and an oesophageal vent. The aim of this study is to compare this device to the LMA ProSeal. The study is approved by the institutional ethic committee. 222 patients will be enrolled in each group. The objectives of the study will be to compare insertion success rate, leak pressure, ventilatory parameters and adverse event rate.

Study Overview

Detailed Description

Supraglottic airway devices are now widely used for surgery requiring general anesthesia. Airway devices are safe and their morbidity rate is very low. The i-gel (Intersurgical Ltd, Wokingham, Berkshire, UK) is a new single-use non-inflatable supraglottic airway device that has not been evaluated in a comparative study.

The aim of this study is to compare i-gel with the LMA ProSeal in a randomized study. Anesthesia protocol is standardized. The supraglottic devices are compared in term of insertion success rate, leak pressure, ventilatory parameters and adverse events. The aim is to demonstrate an enhancement in term of insertion success rate and a diminution of the adverse events. Statistical analysis will used percentage, confidence interval and chi 2 or Fischer's exact test for qualitative data. Quantitative data will be analyzed in mean, standard deviation. Comparison will be made with a student t test or a wilcoxon test. P < 0,05 is statistically significant.

Study Type

Interventional

Enrollment (Actual)

700

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bordeaux, France, 33000
        • Uniersity Hospital, Bordeaux

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Weight > 30 kg
  • Surgery allowing the use of laryngeal mask as airway management
  • Written informed consent

Exclusion Criteria:

  • Difficult intubation criteria (defined by French Anesthesia-Reanimation Society)
  • Pulmonary disease
  • Gastroesophageal reflux antecedent
  • Coeliosurgery
  • Inhalation risk
  • Hiatus hernia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: 1
LMA ProSeal
Laryngeal mask insertion
Other Names:
  • LMA ProSeal
Experimental: 2
I-Gel
Laryngeal mask insertion
Other Names:
  • I-Gel

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Insertion success rate
Time Frame: At firste attempt of insertion
At firste attempt of insertion

Secondary Outcome Measures

Outcome Measure
Time Frame
Perioperative morbidity
Time Frame: Perioperative period
Perioperative period
Airway sealing pressure
Time Frame: Once, when efficient ventilation is reached
Once, when efficient ventilation is reached
Accessibility for stomach tube insertion
Time Frame: Juste after laryngeal mask insertion
Juste after laryngeal mask insertion
Fibre-optic grade
Time Frame: After insertion
After insertion

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anne-Marie CROS, Dr, University Hospital, Bordeaux

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2008

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

February 15, 2008

First Submitted That Met QC Criteria

February 26, 2008

First Posted (Estimated)

February 27, 2008

Study Record Updates

Last Update Posted (Actual)

June 1, 2026

Last Update Submitted That Met QC Criteria

May 27, 2026

Last Verified

January 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX 2007/22
  • 2007-A01095-48 (Other Identifier: ANSM)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Endotracheal Intubation

Clinical Trials on Laryngeal mask insertion (LMA ProSeal)

Subscribe